129 related articles for article (PubMed ID: 2224536)
1. Vasoactive intestinal peptide affects the GABAergic system in the hypothalamic-pituitary axis.
Duvilanski BH; Lasaga M; Seilicovich A; Afione S; Díaz MC; Debeljuk L
Brain Res Bull; 1990 Aug; 25(2):215-9. PubMed ID: 2224536
[TBL] [Abstract][Full Text] [Related]
2. Substance P affects the GABAergic system in the hypothalamo-pituitary axis.
Afione S; Debeljuk L; Seilicovich A; Pisera D; Lasaga M; Díaz MC; Duvilanski B
Peptides; 1990; 11(6):1065-8. PubMed ID: 1708134
[TBL] [Abstract][Full Text] [Related]
3. Effects of passive immunization against vasoactive intestinal peptide on serum prolactin and LH levels.
Lasaga M; Debeljuk L; Afione S; Aleman IT; Duvilanski B
Neuroendocrinology; 1989 Jun; 49(6):574-9. PubMed ID: 2770978
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide (VIP) mediates the effect of estrogens on the dopaminergic tone in the hypothalamic-pituitary axis of ovariectomized (OVX) rats.
Lasaga M; Seilicovich A; Pisera D; Díaz MC; Befumo MF; Duvilanski BH
Endocrine; 1997 Feb; 6(1):53-6. PubMed ID: 9225116
[TBL] [Abstract][Full Text] [Related]
5. Neurokinin A affects the tubero-hypophyseal gabaergic system.
Pisera D; De Laurentiis A; Duvilanski B; Lasaga M; Díaz MC; Seilicovich A
Neuroreport; 1996 Sep; 7(13):2236-40. PubMed ID: 8930996
[TBL] [Abstract][Full Text] [Related]
6. Possible role of vasoactive intestinal peptide in the hyperprolactinemia induced by ethanol.
Seilicovich A; Duvilanski B; Debeljuk L; Lasaga M; Pisera D; Afione S; Traktenberg R; Diaz MC
Regul Pept; 1991 Mar; 33(1):39-44. PubMed ID: 2047543
[TBL] [Abstract][Full Text] [Related]
7. The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.
Murai I; Reichlin S; Ben-Jonathan N
Endocrinology; 1989 Feb; 124(2):1050-5. PubMed ID: 2492217
[TBL] [Abstract][Full Text] [Related]
8. Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats.
Carrillo AJ; Phelps CJ
Endocrinology; 1992 Aug; 131(2):964-9. PubMed ID: 1639033
[TBL] [Abstract][Full Text] [Related]
9. Antisera to vasoactive intestinal polypeptide inhibit basal prolactin release from dispersed anterior pituitary cells.
Hagen TC; Arnaout MA; Scherzer WJ; Martinson DR; Garthwaite TL
Neuroendocrinology; 1986; 43(6):641-5. PubMed ID: 3762862
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal polypeptide mRNA and peptide levels are decreased in the anterior pituitary of the human growth hormone-releasing hormone transgenic mouse.
Hyde JF; Morrison DG; Drake KW; Moore JP; Maley BE
J Neuroendocrinol; 1996 Jan; 8(1):9-15. PubMed ID: 8932732
[TBL] [Abstract][Full Text] [Related]
11. Ablation of the hypothalamic arcuate-median eminence region reduces the concentration of vasoactive intestinal peptide in the anterior pituitary gland of male rats.
Carrillo AJ; Dluzen DE
Brain Res; 1993 Jun; 613(2):281-4. PubMed ID: 8186976
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.
Samson WK; Bianchi R; Mogg RJ; Rivier J; Vale W; Melin P
Endocrinology; 1989 Feb; 124(2):812-9. PubMed ID: 2912703
[TBL] [Abstract][Full Text] [Related]
13. GABAergic activation inhibits the hypothalamic-pituitary-ovaric axis and sexual development in the immature female rat. Associated changes in hypothalamic glutamatergic and taurinergic systems.
Feleder C; Ginzburg M; Wuttke W; Moguilevsky JA; Arias P
Brain Res Dev Brain Res; 1999 Sep; 116(2):151-7. PubMed ID: 10521559
[TBL] [Abstract][Full Text] [Related]
14. Interaction between estradiol and prolactin on vasoactive intestinal peptide concentrations in the hypothalamus and in the anterior pituitary of the female rat.
Maletti M; Rostene WH; Carr L; Scherrer H; Rotten D; Kordon C; Rosselin G
Neurosci Lett; 1982 Oct; 32(3):307-13. PubMed ID: 6891038
[TBL] [Abstract][Full Text] [Related]
15. Hyperprolactinemia reduces vasoactive intestinal peptide in the anterior pituitary glands of rats.
Prysor-Jones RA; Silverlight JJ; Jenkins JS
Neurosci Lett; 1987 Oct; 80(3):333-8. PubMed ID: 3683988
[TBL] [Abstract][Full Text] [Related]
16. Central administration of antiserum to vasoactive intestinal peptide delays and reduces luteinizing hormone and prolactin surges in ovariectomized, estrogen-treated rats.
van der Beek EM; Swarts HJ; Wiegant VM
Neuroendocrinology; 1999 Apr; 69(4):227-37. PubMed ID: 10207274
[TBL] [Abstract][Full Text] [Related]
17. Regulation of anterior pituitary galanin and vasoactive intestinal peptide by oestrogen and prolactin status.
Hammond PJ; Khandan-Nia N; Withers DJ; Jones PM; Ghatei MA; Bloom SR
J Endocrinol; 1997 Feb; 152(2):211-9. PubMed ID: 9071978
[TBL] [Abstract][Full Text] [Related]
18. Effect of ovine prolactin administration on hypothalamic vasoactive intestinal peptide (VIP), gonadotropin releasing hormone I and II content, and anterior pituitary VIP receptors in laying turkey hens.
Rozenboim I; Tabibzadeh C; Silsby JL; el Halawani ME
Biol Reprod; 1993 Jun; 48(6):1246-50. PubMed ID: 8391330
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide and the stimulation of lactotroph growth by oestradiol in rats.
Prysor-Jones RA; Silverlight JJ; Kennedy SJ; Jenkins JS
J Endocrinol; 1988 Feb; 116(2):259-65. PubMed ID: 3351421
[TBL] [Abstract][Full Text] [Related]
20. Neonatal androgenization increases vasoactive intestinal peptide levels in rat anterior pituitary: possible involvement of vasoactive intestinal peptide in the neonatal androgenization-induced hyperprolactinemia.
Watanobe H; Sasaki S; Takebe K
J Endocrinol Invest; 1991 Nov; 14(10):875-9. PubMed ID: 1802925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
